Pairidex is pleased to welcome Stephanie Chrysanthou, PhD, to the team as Senior Scientist. Dr. Chrysanthou brings deep expertise in genomics, stem cell biology, and molecular assay development.

Most recently, Dr. Chrysanthou was Manager of R&D in the Integrated Genomics Operation at Memorial Sloan Kettering Cancer Center. There she led a team that developed new genomic technologies for basic, and translational research at a high-throughput core facility.

Dr. Chrysanthou earned her PhD at the University of Cambridge, UK, where she studied epigenetic regulation in early embryonic development. She then completed a postdoctoral fellowship at Albert Einstein College of Medicine, where she expanded her research to the epigenetic regulation of hematopoietic stem cells and its role in hematologic malignancies.

At Pairidex, she will lead new assay development in our CLIA lab, advancing our mission to reduce uncertainty in leukemia care through ultra-sensitive disease monitoring.